Home Healthcare Drugs Global Vaccine Market Size, by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, Rotavirus, TT, Polio, MMR, Varicella, Dengue, TB, shingles, Rabies), Route (IM, SC, ID, Oral), Patient (Pediatric, Adult), By Region (North America, Europe, Asia Pacific, South America, and the Middle East & Africa), Trend Analysis, Competitive Market Share & Forecast, 2020-2027

Global Vaccine Market Size, by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, Rotavirus, TT, Polio, MMR, Varicella, Dengue, TB, shingles, Rabies), Route (IM, SC, ID, Oral), Patient (Pediatric, Adult), By Region (North America, Europe, Asia Pacific, South America, and the Middle East & Africa), Trend Analysis, Competitive Market Share & Forecast, 2020-2027

Publisher: BlueWeave
Publication Date: May, 2020
Healthcare / Drugs
Pages: 175
Delivery Format: PDF

Report Features
Table of Contents
Pricing
Methodology
Request Sample
Compare Offers
Make an Offer

Vaccines, also known as immunizations, vaccinate a debilitating form of illness into a person, so the body starts creating antibodies or protection besides the disease. Real vaccination has eliminated several conditions, like polio and smallpox, with high death rates. The U.S. Food and Drug Administration newly permitted the first vaccine for dengue disease, the foremost cause of illness amid people existing in the tropics and subtropics. Vaccines can also be used after contamination occurs as a therapeutic. This kind of action has lately developed prevalent for use in immuno-oncology for cancer, making up 15 percent of immunotherapies in 2014. The vaccine market lasts to show development, although the anti-vaccine movement. In the U.S., this drive has created an atmosphere of suspicion around vaccines, despite growing indications of vaccinesÄX%$%X safety and efficacy. The World Health Organization has named vaccine hesitancy as one of the top ten threats fronting public health this year.

The high occurrence rate of infectious diseases and other chronic conditions in the country. Growing aging population base, along with many initiatives taken by the government of India to expand the provision of vaccines in the nation, will positively influence business development. Companies operating in the vaccines market are concentrating on gripping untapped market potential in the country, thereby pushing the market development.

Moreover, the growth of new and improved immunizations for several diseases is a major factor predictable to push growth. The occurrence of several pipeline drugs is expected to lead the development of the Vaccine Market.

The surge in the occurrence of infectious diseases in France, including measles, has stimulated the demand for vaccines in the country after high CAGR during the forecast period. Furthermore, many labors assumed by the French health bodies to make mindfulness about vaccines through social media platforms, including LinkedIn, Facebook, Twitter, have motivated the acceptance of vaccines in France.

North America accounted for a significant portion of the vaccine market in 2018. The large share of North America in the global vaccines market is credited to the high occurrence of infectious diseases and growing savings by government and non-government organizations for vaccine development. On the other hand, the market in Asia is predicted to list the highest growth during the prediction period. Factors such as the growing healthcare spending and growing disposable income, government initiatives, and the occurrence of a large patient people are motivating the growth of the vaccine market in Asia.

The Asia Pacific region is predictable to bystander the firmest development over the prediction period, credited by the rising target people base with high-unmet clinical needs. In addition, the growing disposable income level and the increasing mindfulness regarding the merits of vaccination in emerging economies of the Asia Pacific region are further predictable to foster market development.

Growth Drivers

Increase in incidence of both viral and bacterial infectious diseases

An escalation in communicable diseases universal, including Ebola, influenza, swine flu, hepatitis, tuberculosis, diphtheria, and meningococcal and pneumococcal diseases, is one of the chief drivers of market growth. Vaccinations are essentially administered to people of different age groups, which strengthens their resistant system during a lifetime and offers protection against dissimilar types of infectious diseases—besides, emerging vaccines (Zika vaccines, dengue vaccines, cancer vaccines, and others), making of technologically advanced vaccines, advancements in vaccine delivery devices, and increase in immunization programs addition the market growth.

Strong Supply backed up by Robust R&D to drive the Vaccines Market

One of the vital and noteworthy drivers for market growth is the growing source of vaccines crosswise the sphere to meet the unmet needs and abide by the immunization policies to eradicate widespread diseases. Pharmaceutical companies, government foundations, international organizations, and hospitals are strongly absorbed in providing cost-effective and regular vaccination to people universal. A government investigation in all the countries has become active in safeguarding that suggested Vaccines at a minimum cost or no cost vaccinate every individual.

Select Plan

1 User License $4,250

Site License License $4,950

Are you looking for a Consultant?

Email Us

Get a Quote

Offer Amount (Per user license)	Retail price (Per user license)
$ .00	$4,250

Are you looking for a Consultant?

Customers Who Viewed This Item Also Viewed